Monoclonal B lymphocytosis (MBL) is a lymphoproliferative condition characterised by expansion of a B-cell clone in peripheral blood, with an often indolent clinical course. The presence of a B clonal population alone is several hundred times more common in the general population than chronic lymphocytic leukaemia and other non-Hodgkin's lymphoma subtypes, it usually does not represent a malignant condition and it requires follow-up only, without specific treatment. There are few studies describing MBL in solid organ transplant recipients, thus, the concern is raised when enrolling MBL affected subjects in waiting lists. We report the experience of a patient affected by MBL who underwent kidney transplantation, with particular attention to preoperative screening and immunosuppressants impact on post-transplant lymphoproliferative disease risk, to aid clinicians in the evaluation process of transplant candidates affected by similar conditions. 2021 BMJ Publishing Group Limited. Published by BMJ.

Monoclonal B lymphocytosis in a kidney transplant recipient / Plessi, J.; Mori, G.; Magistroni, R.; Cappelli, G.. - In: BMJ CASE REPORT. - ISSN 1757-790X. - 14:6(2021), pp. e242889-e242890. [10.1136/bcr-2021-242889]

Monoclonal B lymphocytosis in a kidney transplant recipient

Plessi J.;Mori G.;Magistroni R.;Cappelli G.
2021

Abstract

Monoclonal B lymphocytosis (MBL) is a lymphoproliferative condition characterised by expansion of a B-cell clone in peripheral blood, with an often indolent clinical course. The presence of a B clonal population alone is several hundred times more common in the general population than chronic lymphocytic leukaemia and other non-Hodgkin's lymphoma subtypes, it usually does not represent a malignant condition and it requires follow-up only, without specific treatment. There are few studies describing MBL in solid organ transplant recipients, thus, the concern is raised when enrolling MBL affected subjects in waiting lists. We report the experience of a patient affected by MBL who underwent kidney transplantation, with particular attention to preoperative screening and immunosuppressants impact on post-transplant lymphoproliferative disease risk, to aid clinicians in the evaluation process of transplant candidates affected by similar conditions. 2021 BMJ Publishing Group Limited. Published by BMJ.
14
6
e242889
e242890
Monoclonal B lymphocytosis in a kidney transplant recipient / Plessi, J.; Mori, G.; Magistroni, R.; Cappelli, G.. - In: BMJ CASE REPORT. - ISSN 1757-790X. - 14:6(2021), pp. e242889-e242890. [10.1136/bcr-2021-242889]
Plessi, J.; Mori, G.; Magistroni, R.; Cappelli, G.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1249407
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact